Author:
Newton Paul N,Green Michael D,Mildenhall Dallas C,Plançon Aline,Nettey Henry,Nyadong Leonard,Hostetler Dana M,Swamidoss Isabel,Harris Glenn A,Powell Kristen,Timmermans Ans E,Amin Abdinasir A,Opuni Stephen K,Barbereau Serge,Faurant Claude,Soong Ray CW,Faure Kevin,Thevanayagam Jonarthan,Fernandes Peter,Kaur Harparkash,Angus Brian,Stepniewska Kasia,Guerin Philippe J,Fernández Facundo M
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference51 articles.
1. World Health Organization: WHO guidelines for the treatment of malaria. Geneva. 2010, Accessed 12 March 2011, [
http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
]
2. Arrow KJ, Panosian CB, Gelband H: Saving lives, buying time: Economics of malaria drugs in an age of resistance. 2004, Washington (DC): Institute of Medicine of the National Academies, Accessed 12 October 2011, [
http://www.nap.edu/books/0309092183/html/
]
3. White NJ: Qinghaosu (artemisinin): the price of success. Science. 2008, 320: 330-334. 10.1126/science.1155165.
4. World Health Organization: Country antimalarial drug policies: by region. Geneva. 2009, Accessed 12 March 2011, [
http://www.who.int/malaria/am_drug_policies_by_region_afro/en/index.html
]
5. World Health Organization: Executive Board 124th Session Provisional agenda item 4.11. Counterfeit medical products. EB124. Geneva. 2008,
http://www.who.int/gb/ebwha/pdf_files/EB124/B124_14-en.pdf
. With corrigendum-see
http://apps.who.int/gb/ebwha/pdf_files/EB124/B124_14Corr1-en.pdf
. Accessed 12 March 2011